Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

NCT03583736 | Withdrawn

• 1 other identifier: CASE3818
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

This project aims to evaluate whether rapid first contact with the oncologist the same day or the next day after pathologic diagnosis contributes to a decreased time to treatment, decreased patient anxiety and increased patient satisfaction.

Conditions

Uterine Cancer

Outcome Measures

Primary Outcomes (1)

• Time to treatment following diagnosis to treatment initiation

  How long between diagnosis to treatment

  30 days

Secondary Outcomes (3)

• Amount of anxiety demonstrated when virtual visits are added

  30 days

• Number of patients willing to pay for a virtual visit

  30 days

• Number of patients with improved satisfaction scores

  30 days

Study Arms (2)

Rapid first contact virtual visit

ACTIVE COMPARATOR

Subjects will accept the offer of a virtual visit after being contacted by the nurse to offer a virtual visit with the oncologist prior to the in person office visit once a diagnosis has been confirmed. Subjects will be randomized after accepting offer of a virtual visit.

Behavioral: Virtual visit

First contact in person office visit

PLACEBO COMPARATOR

Subjects will accept the offer of a virtual visit after being contacted by the nurse to offer a virtual visit with the oncologist prior to the in person office visit once a diagnosis has been confirmed. Subjects will be randomized after accepting offer of a virtual visit.

Behavioral: Office visit

Interventions

Virtual visit BEHAVIORAL

Virtual visit with oncologist following uterine cancer diagnosis prior to scheduled office visit.

Rapid first contact virtual visit

Office visit BEHAVIORAL

Scheduled office visit with oncologist following uterine cancer diagnosis.

First contact in person office visit

Eligibility Criteria

• Age: 18 Years+
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Uterine cancer diagnosis on biopsy read by Cleveland Clinic Pathology Department
• Patients must be willing to participate in a virtual visit as the initial meeting with an oncologist at the Cleveland Clinic.
• Receive care at Fairview Hospital, Hillcrest Hospital or Cleveland Clinic Main Campus
• Internet connected smartphone or internet connected computer with webcam
• Participants must have email access
• English speaking
• Competent to make clinic decisions

You may not qualify if:

• No diagnosis of uterine cancer

Sponsors & Collaborators

• Case Comprehensive Cancer Center: lead

MeSH Terms

Conditions

Uterine Neoplasms

Interventions

Office Visits

Condition Hierarchy (Ancestors)

Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases

Intervention Hierarchy (Ancestors)

Professional Practice; Organization and Administration; Health Services Administration

Study Officials

• Jason Knight, MD

  Cleveland Clinic, Case Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 27, 2018
• First Posted: July 11, 2018
• Study Start: June 27, 2018
• Primary Completion: June 1, 2020
• Study Completion: June 1, 2020
• Last Updated: June 30, 2020

Record last verified: 2020-06